( February 25, 2026, 8:18 AM EST) -- WASHINGTON, D.C. — Cases alleging that Dupixent, a prescription medication used for the treatment of asthma and inflammatory skin conditions, may cause cutaneous T-cell lymphoma (CTCL), a rare type of cancer that affects white blood cells called T cells, or T lymphocytes, should be centralized by the U.S. Judicial Panel on Multidistrict Litigation (JPMDL) in a federal court in Georgia, three individuals argue in a motion to transfer....